InvestorsHub Logo
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

Re: petemantx post# 277445

Wednesday, 12/04/2019 10:34:21 AM

Wednesday, December 04, 2019 10:34:21 AM

Post# of 402939
"Does any bio have any proof that their drug will work or be accepted by the FDA prior to actually getting approval by the FDA? Of course not." I could not agree more.

"All they have to go on is pre-clinical and clinical trial results.
If those are good, expectations for partnering are justified." For the most part public companies are obligated to share their findings with shareholders', honestly. I believe man investor's have become somewhat skeptical based upon r.o.i compared to company proclamations.

"So for an investor to supposedly have thrown a ton of cash into a bio investment, suffer major losses due to buying at the wrong time or buying too early in the life cycle of the clinical trials, then IMO that makes them one hell of a poor investor if they then claim the risk was too great and is still too great far into the trial cycle." I guess some are better at reading the tea leaves than others-https://investorshub.advfn.com/boards/read_msg.aspx?message_id=80937422.

"Brilacidin OM keeps regularly checking off every box that must be stamped prior to approval and until it fails to do so my expectation is for it to succeed. Having done well thru a P2 means that many more times will the drug in trials succeed as opposed to failing as only a P3 is left to pass." Sounds failiar-https://investorshub.advfn.com/boards/read_msg.aspx?message_id=80937422

"Risk still at hand, yes. But risk that many BPs will accept in their quest to land a drug with multi-billion dollar per year potential." Not much risk left, only pennies to loose. Where have you gone Boston Business Journal?

"Like our chances." Never been better?!??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News